Home LiteratureArticle Details
PMID: 2148290 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Lymphoid specific gene expression of the adenovirus early region 3 promoter is mediated by NF-kappa B binding motifs.

The EMBO journal ·Vol. 9 ·No. 13 ·1990-12-00 ·Pages 4435-42

Williams JL, Garcia J, Harrich D, Pearson L, Wu F, Gaynor R

Abstract

A primary site of infection by human adenoviruses is lymphoid cells. However, analysis of the viral control elements and the cellular factors that regulate adenoviral gene expression in lymphocytes has not been reported. The adenovirus early region 3 (ES) gene products are involved in the maintenance of viral persistence by complexing with the class I MHC antigens, thus preventing their cell surface expression with a resultant decrease in host immunologic destruction. To determine whether different cellular factors were involved in E3 regulation in lymphocytes as compared with HeLa cells, both DNA binding and transfection analysis with the E3 promoter in both cell types were performed. These studies detected two novel domains referred to as L1 and L2 with a variety of lymphoid but not HeLa extracts. Each of these domains possessed strong homology to motifs previously found to bind the cellular factor NF-kappa B. Transfections of E3 constructs linked to the chloramphenicol acetyltransferase gene revealed that mutagenesis of the distal NF-kappa B motif (L2) had minimal effects on promoter expression in HeLa cells, but resulted in dramatic decreases in expression by lymphoid cells. In contrast, mutagenesis of proximal NF-kappa B motif (L1) had minimal effects on gene expression in both HeLa cells and lymphoid cells but resulted in a small, but reproducible, increase in gene expression in lymphoid cells when coupled to the L2 mutation. Reversing the position and subsequent mutagenesis of the L1 and L2 domains indicated that the primary sequence of these motifs rather than their position in the E3 promoter was critical for regulating gene expression.(ABSTRACT TRUNCATED AT 250 WORDS)

MeSH Terms
Adenovirus Early Proteins Base Sequence Binding Sites Chloramphenicol O-Acetyltransferase/genetics DNA/chemistry Deoxyribonuclease I Gene Expression Regulation Genes, Viral HeLa Cells Humans Lymphocytes/metabolism Molecular Sequence Data Mutation NF-kappa B/genetics Oncogene Proteins, Viral/biosynthesis,genetics Promoter Regions, Genetic Sequence Homology, Nucleic Acid
Chemicals
Adenovirus Early Proteins NF-kappa B Oncogene Proteins, Viral DNA Chloramphenicol O-Acetyltransferase Deoxyribonuclease I
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Williams J L
Department of Medicine, UCLA School of Medicine.
Garcia J
Harrich D
Pearson L
Wu F
Gaynor R
References (55)
55 references, click to expand
  1. An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigens.
    Cell. 1985 Jul;41(3):987-97 PMID: 3924414
  2. HTLV-I tax induces cellular proteins that activate the kappa B element in the IL-2 receptor alpha gene.
    Science. 1988 Sep 23;241(4873):1652-5 PMID: 2843985
  3. Group C adenovirus DNA sequences in human lymphoid cells.
    J Virol. 1986 Jul;59(1):189-92 PMID: 3486983
  4. Multiple nuclear factors interact with the immunoglobulin enhancer sequences.
    Cell. 1986 Aug 29;46(5):705-16 PMID: 3091258
  5. Cell-type specific protein binding to the enhancer of simian virus 40 in nuclear extracts.
    Nature. 1986 Oct 9-15;323(6088):544-8 PMID: 3020434
  6. Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism.
    Cell. 1986 Dec 26;47(6):921-8 PMID: 3096580
  7. The role of the kappa enhancer and its binding factor NF-kappa B in the developmental regulation of kappa gene transcription.
    Cell. 1987 Jan 16;48(1):121-8 PMID: 3098435
  8. Adenoviruses of subgenera B, C, D, and E modulate cell-surface expression of major histocompatibility complex class I antigens.
    Proc Natl Acad Sci U S A. 1986 Dec;83(24):9665-9 PMID: 3467330
  9. Adenovirus promoters and E1A transactivation.
    Annu Rev Genet. 1986;20:45-79 PMID: 3028247
  10. "E3/19K" protein of adenovirus type 2 inhibits lysis of cytolytic T lymphocytes by blocking cell-surface expression of histocompatibility class I antigens.
    Proc Natl Acad Sci U S A. 1987 Mar;84(5):1356-60 PMID: 2950523
  11. Binding of a nuclear factor to a regulatory sequence in the promoter of the mouse H-2Kb class I major histocompatibility gene.
    Mol Cell Biol. 1987 Jan;7(1):305-13 PMID: 3561391
  12. An inducible transcription factor activates expression of human immunodeficiency virus in T cells.
    Nature. 1987 Apr 16-22;326(6114):711-3 PMID: 3031512
  13. Productive infection of cultured human lymphoid cells by adenovirus.
    J Virol. 1987 May;61(5):1466-72 PMID: 3573145
  14. Protein-binding sites in Ig gene enhancers determine transcriptional activity and inducibility.
    Science. 1987 Jun 19;236(4808):1573-7 PMID: 3109035
  15. Discrete elements within the SV40 enhancer region display different cell-specific enhancer activities.
    EMBO J. 1987 Apr;6(4):1017-25 PMID: 3036487
  16. Upstream regulatory regions required to stabilize binding to the TATA sequence in an adenovirus early promoter.
    Nucleic Acids Res. 1987 Oct 26;15(20):8367-85 PMID: 2959908
  17. Identification and purification of EBP1: a HeLa cell protein that binds to a region overlapping the 'core' of the SV40 enhancer.
    Genes Dev. 1988 Aug;2(8):991-1002 PMID: 2844627
  18. I kappa B: a specific inhibitor of the NF-kappa B transcription factor.
    Science. 1988 Oct 28;242(4878):540-6 PMID: 3140380
  19. Nuclear factor NF-kappa B can interact functionally with its cognate binding site to provide lymphoid-specific promoter function.
    EMBO J. 1988 Oct;7(10):3109-13 PMID: 3141147
  20. Repeated B motifs in the human immunodeficiency virus type I long terminal repeat enhancer region do not exhibit cooperative factor binding.
    Proc Natl Acad Sci U S A. 1988 Dec;85(24):9406-10 PMID: 3200827
  21. The NF-kappa B-binding site mediates phorbol ester-inducible transcription in nonlymphoid cells.
    Mol Cell Biol. 1988 Aug;8(8):3526-31 PMID: 3145412
  22. Functionally distinct NF-kappa B binding sites in the immunoglobulin kappa and IL-2 receptor alpha chain genes.
    Science. 1989 Apr 28;244(4903):466-9 PMID: 2497520
  23. Epidermal growth factor binding induces a conformational change in the external domain of its receptor.
    EMBO J. 1989 Dec 20;8(13):4115-23 PMID: 2591370
  24. The SV40 TC-II(kappa B) and the related H-2Kb enhansons exhibit different cell type specific and inducible proto-enhancer activities, but the SV40 core sequence and the AP-2 binding site have no enhanson properties.
    EMBO J. 1989 Dec 20;8(13):4205-14 PMID: 2556264
  25. NF-kappa B as inducible transcriptional activator of the granulocyte-macrophage colony-stimulating factor gene.
    Mol Cell Biol. 1990 Mar;10(3):1281-6 PMID: 2406568
  26. Adenovirus early region 3 promoter regulation by E1A/E1B is independent of alterations in DNA binding and gene activation of CREB/ATF and AP1.
    J Virol. 1990 May;64(5):2004-13 PMID: 2139139
  27. Alterations in binding characteristics of the human immunodeficiency virus enhancer factor.
    J Virol. 1988 Jan;62(1):218-25 PMID: 3257103
  28. Mapping of late adenovirus genes by cell-free translation of RNA selected by hybridization to specific DNA fragments.
    Proc Natl Acad Sci U S A. 1975 Apr;72(4):1344-8 PMID: 1093178
  29. Characteristics of a human cell line transformed by DNA from human adenovirus type 5.
    J Gen Virol. 1977 Jul;36(1):59-74 PMID: 886304
  30. DNAse footprinting: a simple method for the detection of protein-DNA binding specificity.
    Nucleic Acids Res. 1978 Sep;5(9):3157-70 PMID: 212715
  31. Molecular association between transplantation antigens and cell surface antigen in adenovirus-transformed cell line.
    Proc Natl Acad Sci U S A. 1978 Nov;75(11):5674-8 PMID: 310123
  32. Purification and characterization of an early glycoprotein from adenovirus type 2-infected cells.
    J Virol. 1979 Mar;29(3):938-48 PMID: 448802
  33. Pre-early adenovirus 5 gene product regulates synthesis of early viral messenger RNAs.
    Cell. 1979 Aug;17(4):935-44 PMID: 487437
  34. An adenovirus type 5 early gene function regulates expression of other early viral genes.
    Proc Natl Acad Sci U S A. 1979 Aug;76(8):3665-9 PMID: 291030
  35. Synthesis and genomic site for an adenovirus type 2 early glycoprotein.
    J Mol Biol. 1980 Feb 5;136(4):375-94 PMID: 7365790
  36. Expression of unselected adenovirus genes in human cells co-transformed with the HSV-1 tk gene and adenovirus 2 DNA.
    Cell. 1980 Sep;21(2):453-63 PMID: 6250722
  37. Biochemical and biological characterization of lymphocyte regulatory molecules. V. Identification of an interleukin 2-producing human leukemia T cell line.
    J Exp Med. 1980 Dec 1;152(6):1709-19 PMID: 6778951
  38. Human cutaneous T cell lymphoma and leukemia cell lines produce and respond to T cell growth factor.
    J Exp Med. 1981 Nov 1;154(5):1403-18 PMID: 6975346
  39. An adenovirus glycoprotein binds heavy chains of class I transplantation antigens from man and mouse.
    Nature. 1982 Sep 9;299(5879):175-8 PMID: 6287288
  40. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.
    Mol Cell Biol. 1982 Sep;2(9):1044-51 PMID: 6960240
  41. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.
    Nucleic Acids Res. 1983 Mar 11;11(5):1475-89 PMID: 6828386
  42. Complex formation of class I transplantation antigens and a viral glycoprotein.
    J Biol Chem. 1983 Sep 10;258(17):10594-8 PMID: 6885796
  43. T4 positive human neoplastic cell lines susceptible to and permissive for HTLV-III.
    Lancet. 1984 Dec 22;2(8417-8418):1472-3 PMID: 6151082
  44. A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus.
    Cell. 1985 Jun;41(2):521-30 PMID: 2985280
  45. Nonpermissivity of human peripheral blood lymphocytes to adenovirus type 2 infection.
    J Virol. 1988 Jan;62(1):341-5 PMID: 3334747
  46. Cell-specific activity of the constituent elements of the simian virus 40 enhancer.
    Proc Natl Acad Sci U S A. 1987 Nov;84(22):7881-5 PMID: 2825168
  47. Purification of KBF1, a common factor binding to both H-2 and beta 2-microglobulin enhancers.
    EMBO J. 1987 Nov;6(11):3317-24 PMID: 3322806
  48. Identification of factors that interact with the E1A-inducible adenovirus E3 promoter.
    Genes Dev. 1987 Dec;1(10):1132-46 PMID: 2828166
  49. Two transcription factors, NF-kappa B and H2TF1, interact with a single regulatory sequence in the class I major histocompatibility complex promoter.
    Proc Natl Acad Sci U S A. 1988 Feb;85(3):723-7 PMID: 3422454
  50. Oligonucleotide that binds nuclear factor NF-kappa B acts as a lymphoid-specific and inducible enhancer element.
    Proc Natl Acad Sci U S A. 1988 Mar;85(5):1482-6 PMID: 3125549
  51. Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-kappa B transcription factor.
    Cell. 1988 Apr 22;53(2):211-7 PMID: 3129195
  52. The same inducible nuclear proteins regulates mitogen activation of both the interleukin-2 receptor-alpha gene and type 1 HIV.
    Cell. 1988 Jun 3;53(5):827-36 PMID: 2836068
  53. Identification and purification of a human immunoglobulin-enhancer-binding protein (NF-kappa B) that activates transcription from a human immunodeficiency virus type 1 promoter in vitro.
    Proc Natl Acad Sci U S A. 1988 Jul;85(13):4700-4 PMID: 3133660
  54. Purification of the human immunodeficiency virus type 1 enhancer and TAR binding proteins EBP-1 and UBP-1.
    EMBO J. 1988 Jul;7(7):2117-30 PMID: 3138113
  55. Impaired intracellular transport of class I MHC antigens as a possible means for adenoviruses to evade immune surveillance.
    Cell. 1985 Nov;43(1):215-22 PMID: 2934137
Article Info
Journal
The EMBO journal
Abbr.
EMBO J
ISSN
0261-4189
Published
1990-12-00
Pages
4435-42
Language
English
Region
England
NLM ID
8208664
PMCID
PMC552236
Subset
IM
Grants
NCI NIH HHS · CA30981 · United States
NIGMS NIH HHS · GM 07104-15 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]